Intragen

Intragen, marketed in full as Intragen Cosmetic Trichology, is a professional scalp-and-hair-care line developed under Revlon Professional, the salon division built around Spain's Colomer Group [5]. The range set out to treat common scalp and hair complaints — hair loss, dandruff, oiliness and sensitivity — through shampoos, concentrate treatments and transdermal patches sold through professional channels. It is no longer listed among Revlon Professional's current care brands, and the line is best described as dormant: several variants have been flagged as discontinued by retailers, while residual stock has continued to surface as "last items in stock" at European salon resellers [9].

No source records a definitive founding year for Intragen. The earliest verifiable trace of the line is a September 2009 beauty-press review of its anti-hair-loss treatment concentrate, which places the product in the market by at least that year [4].

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

Intragen sits within Revlon Professional, the salon-focused business associated with the Colomer Group. The Colomer Group was founded in 1933 and based in Barcelona; it grew out of Revlon's former professional division, which Revlon sold to private-equity firm CVC Capital Partners in 2000 [6]. In October 2013 Revlon reabsorbed the business, paying about 660 million US dollars to reacquire the Colomer Group and its salon brands [7]. At the time of that deal the group's portfolio centred on Revlon Professional hair care alongside names such as Orofluido, UniqOne, CND and American Crew, and the broader Revlon stable extends to Elizabeth Arden, Cutex and Halston [6]. Retailer and editorial descriptions consistently credit the Intragen complex to "Colomer Group – Revlon Professional," and the line is named as one of the care series in the Revlon Professional lineup [8].

Revlon Professional presented Intragen as a "360° scalp and hair therapy," structured around four targeted areas: anti-hair-loss, dandruff control, sebum balance and relief for sensitive scalps. According to the company's recurring line copy, the range is hypoallergenic, built on natural active ingredients and tested on volunteers with reactive skin. The positioning is clinical rather than cosmetic — the products are framed as treatments for scalp conditions that, as the brand puts it, "would otherwise remain unaddressed," and are pitched at the professional, salon-distributed tier rather than mass retail.

At the centre of the line is a patented anti-hair-loss complex that the brand markets as the "Intragen 5" system. Third-party descriptions list its active ingredients as extracts of hops, rosemary and semburi together with silicon and panthenol compounds [2]. The format spans shampoos, vial-based concentrate treatments applied directly to the hair roots, and transdermal anti-hair-loss patches. The patches are described as carrying a highly concentrated formula intended to prolong the hair's growth cycle by blocking the enzyme 5-alpha-reductase [10].

Intragen's marketing leans on stated clinical and survey results. The company cites a six-month clinical test on both men and women said to show increased hair density and greater resistance to loss [4]. A separate independent survey of 290 people with alopecia is reported to have found that, after two months, 69% expressed high satisfaction with the patch, 75% reported increased hair density and 70% reported stronger hair [2]. These figures come from the brand's own materials and third-party clinic write-ups rather than independent verification.

Intragen is dormant. It no longer appears among Revlon Professional's actively marketed care series, which now centres on names such as Eksperience, RE/START, Orofluido, UniqOne, Equave, Style Masters and ProYou [8]. Some Intragen variants have been explicitly marked as discontinued and not slated for restock, while others have lingered as final stock at European beauty and salon retailers into 2024–2025 [9]. The pattern points to a line that has been wound down rather than one under active development.

A note on dating: a search snippet had attributed the line's earliest beauty-press review to October 2013, but the review page itself carries a publication date of 26 September 2009 [4]. The 2009 date is used here as the verified lower bound for the line's existence; it does not indicate the line's founding year, which remains unknown.